Trials / Completed
CompletedNCT04871490
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine whether a blood test for HPV DNA can improve diagnosis of HPV-positive oropharynx cancer (HPV-OPC).
Detailed description
The diagnosis of HPV-OPC is often delayed. In this study, individuals with signs or symptoms potentially related to HPV-OPC, such as unexplained throat pain, tonsil or tongue base asymmetry, or a neck mass, will have their blood tested for circulating HPV DNA. A positive test may indicate that their symptoms are caused by HPV-OPC, and their treating physician will be encouraged to complete all the necessary testing to determine whether this is the case.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood test for HPV DNA | All participants will have blood tested for HPV DNA. |
Timeline
- Start date
- 2021-03-24
- Primary completion
- 2022-12-15
- Completion
- 2024-12-31
- First posted
- 2021-05-04
- Last updated
- 2025-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04871490. Inclusion in this directory is not an endorsement.